Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Role of copper in progression of clear cell renal cell carcinoma [RNA-seq]

ABSTRACT: Role of copper in progression of clear cell renal cell carcinoma [RNA-seq]

PROVIDER: PRJNA1051628 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR27190230.fastq.gz	Fastqsanger.gz
	SRR27190231.fastq.gz	Fastqsanger.gz
	SRR27190232.fastq.gz	Fastqsanger.gz
	SRR27190233.fastq.gz	Fastqsanger.gz
	SRR27190234.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Role of copper in progression of clear cell renal cell carcinoma [RNA-seq]

2024-10-18 | GSE250028 | GEO

Role of copper in progression of clear cell renal cell carcinoma [Spatial transcriptomics]

Project description:Role of copper in progression of clear cell renal cell carcinoma [Spatial transcriptomics]

| PRJNA1052130 | ENA

Role of copper in progression of clear cell renal cell carcinoma [Spatial transcriptomics]

Project description:Copper (Cu) is an essential trace element required for mitochondrial respiration. We show that Cu drives coordinated metabolic remodeling of bioenergy, biosynthesis and redox homeostasis and promotes tumor growth and progression of clear cell renal cell carcinoma (ccRCC). Late-stage ccRCCs accumulate Cu and allocate it to cytochrome c oxidase stimulating bioenergy production. Cu induces TCA cycle-dependent oxidation of glucose and its utilization for biosynthesis of a glutathione pool that protects against H2O2 generated during mitochondrial respiration, therefore coordinating bioenergy production with redox protection. Single cell transcriptomics determined induction of mitochondrial electron transport chain, expression of NRF2 targets and glutathione biosynthesis, and decrease in HIF activity, the hallmark of ccRCC, during disease progression. Spatial transcriptomics identified that cancer cells with proliferative phenotype are embedded in clusters of cells with oxidative metabolism supporting effects of metabolic states on ccRCC progression. Our work establishes novel vulnerabilities with potential for therapeutic interventions in ccRCC.

2024-10-18 | GSE250163 | GEO

Clear-cell renal cell carcinomas tumors

Project description:Whole genome expression of 39 clear-cell renal cell carcinomas tumors 39 frozen tissue from recent nephrectomies for clear-cell renal cell carcinoma; association with clinical characteristics

2011-05-28 | E-GEOD-29609 | biostudies-arrayexpress

Proteomics of renal clear cell carcinoma

Project description:Proteomic analysis of renal clear cell carcinoma using data dependent acquisition (DDA) based mass spectrometry

2025-11-03 | PXD065922 | Pride

Gene expression analysis of non-clear-cell renal cell carcinoma and clear-cell renal cell carcinoma kidney cancers

Project description:Gene expression analysis of non-clear-cell renal cell carcinoma and clear-cell renal cell carcinoma kidney cancers

| PRJNA1375726 | ENA

Understanding the biological processes of clear cell renal carcinoma carcinogenesis: an integrative multi-omics approach.

Project description:Multi-Omics analysis to gain novel insights into clear cell renal carcinoma aetiology and progression. The DNA methylation data of 121 clear clear renal carcinoma (ccRCC) were integrated with WGS and transcriptomic data using Multi-Omics Factor Analysis (MOFA) to detect the inter-patient variations related to aetiological and disease progression related factors.

2024-06-07 | GSE269180 | GEO

Clear-cell renal cell carcinomas tumors

Project description:Whole genome expression of 39 clear-cell renal cell carcinomas tumors

2011-05-28 | GSE29609 | GEO

CTSP Kidney Renal Clear Cell Carcinoma E2805T6

Project description:CTSP Kidney Renal Clear Cell Carcinoma E2805T6

| PRJNA562745 | ENA

microRNA Profile in Stage I Clear Cell Renal Cell Carcinoma Predicts Progression to Metastatic Disease

Project description:microRNA Profile in Stage I Clear Cell Renal Cell Carcinoma Predicts Progression to Metastatic Disease

| PRJNA545463 | ENA